Citations (56)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Mackenzie T. Jones, Martin T. Strassnig & Philip D. Harvey. (2020) Emerging 5-HT receptor antagonists for the treatment of Schizophrenia. Expert Opinion on Emerging Drugs 25:2, pages 189-200.
Read now
Read now
Articles from other publishers (55)
Rafaela Sousa, Eunice Magalhães, Cláudia Camilo & Carla Silva. (2023) Childhood Poly-victimization and Adults’ Psychoticism: A Moderated Mediation Model Testing an Affective Pathway. Anuario de Psicología Jurídica, pages 000-000.
Crossref
Crossref
Gunnhild E. Hoprekstad, Eirik Kjelby, Rolf Gjestad, Farivar Fathian, Tor K. Larsen, Solveig K. Reitan, Maria Rettenbacher, Anja Torsvik, Silje Skrede, Erik Johnsen & Rune A. Kroken. (2023) Depression trajectories and cytokines in schizophrenia spectrum disorders - A longitudinal observational study. Schizophrenia Research 252, pages 77-87.
Crossref
Crossref
Vincenzo Micale, Martina Di Bartolomeo, Serena Di Martino, Tibor Stark, Bernardo Dell'Osso, Filippo Drago & Claudio D'Addario. (2023) Are the epigenetic changes predictive of therapeutic efficacy for psychiatric disorders? A translational approach towards novel drug targets. Pharmacology & Therapeutics 241, pages 108279.
Crossref
Crossref
Tibor Stark, Fabio Arturo Iannotti, Serena Di Martino, Martina Di Bartolomeo, Jana Ruda-Kucerova, Fabiana Piscitelli, Carsten T. Wotjak, Claudio D’Addario, Filippo Drago, Vincenzo Di Marzo & Vincenzo Micale. (2022) Early Blockade of CB1 Receptors Ameliorates Schizophrenia-like Alterations in the Neurodevelopmental MAM Model of Schizophrenia. Biomolecules 12:1, pages 108.
Crossref
Crossref
Patrick Heller, Larisa Morosan, Deborah Badoud, Manon Laubscher, Lisa Jimenez Olariaga, Martin Debbané, Hans Wolff & Stéphanie Baggio. (2022) Prevalence Rates and Evolution of Psychiatric Disorders Among Incarcerated Youths in Comparison With Non-incarcerated Youths. Frontiers in Psychiatry 12.
Crossref
Crossref
Subash Raj Susai, Sophie Sabherwal, David Mongan, Melanie Föcking & David R. Cotter. (2021) Omega‐3 fatty acid in ultra‐high‐risk psychosis: A systematic review based on functional outcome. Early Intervention in Psychiatry 16:1, pages 3-16.
Crossref
Crossref
Abbas F. Almulla, Khalid F. Al-Rawi, Michael Maes & Hussein Kadhem Al-Hakeim. (2021) In schizophrenia, immune-inflammatory pathways are strongly associated with depressive and anxiety symptoms, which are part of a latent trait which comprises neurocognitive impairments and schizophrenia symptoms.. Journal of Affective Disorders 287, pages 316-326.
Crossref
Crossref
S. Youn, L.J. Phillips, G.P. Amminger, G. Berger, E.Y.H. Chen, L. de Haan, J.A. Hartmann, I.B. Hickie, S. Lavoie, C. Markulev, P.D. McGorry, N. Mossaheb, D.H. Nieman, M. Nordentoft, A. Riecher-Rössler, M.R. Schäfer, M. Schlögelhofer, S. Smesny, A. Thompson, S. Verma, H.P. Yuen, A.R. Yung & B. Nelson. (2020) Basic symptoms in young people at ultra-high risk of psychosis: Association with clinical characteristics and outcomes. Schizophrenia Research 216, pages 255-261.
Crossref
Crossref
Christina Wenneberg, Birte Yding Glenthøj, Carsten Hjorthøj, Frederik Johan Buchardt Zingenberg, Louise Birkedal Glenthøj, Egill Rostrup, Brian Villumsen Broberg & Merete Nordentoft. (2020) Cerebral glutamate and GABA levels in high-risk of psychosis states: A focused review and meta-analysis of 1H-MRS studies. Schizophrenia Research 215, pages 38-48.
Crossref
Crossref
Lindsay H. Dewa, Mary Lavelle, Katy Pickles, Caroline Kalorkoti, Jack Jaques, Sofia Pappa & Paul Aylin. (2019) Young adults’ perceptions of using wearables, social media and other technologies to detect worsening mental health: A qualitative study. PLOS ONE 14:9, pages e0222655.
Crossref
Crossref
Wanting Ren, Xiaoling Liu, Longzhen Cheng, Guoxiang Wang, Xu Liu, Lichao Peng & Yun Wang. (2019) Embryonic Ketamine Produces a Downregulation of Prefrontal Cortex NMDA Receptors and Anxiety-Like Behavior in Adult Offspring. Neuroscience 415, pages 18-30.
Crossref
Crossref
Johannes L. Roos. 2019. Genetiese bevindings in ‘n groep Afrikaners met skisofrenie. Genetiese bevindings in ‘n groep Afrikaners met skisofrenie.
Lindsay H. Dewa, Elizabeth Cecil, Lynne Eastwood, Ara Darzi & Paul Aylin. (2018) Indicators of deterioration in young adults with serious mental illness: a systematic review protocol. Systematic Reviews 7:1.
Crossref
Crossref
Ravit Hadar, Le Dong, Lucia del-Valle-Anton, Dilansu Guneykaya, Mareike Voget, Henriette Edemann-Callesen, Regina Schweibold, Anais Djodari-Irani, Thomas Goetz, Samuel Ewing, Helmut Kettenmann, Susanne A. Wolf & Christine Winter. (2017) Deep brain stimulation during early adolescence prevents microglial alterations in a model of maternal immune activation. Brain, Behavior, and Immunity 63, pages 71-80.
Crossref
Crossref
Subho Chakrabarti. (2017) Preventive strategies for severe mental disorders. Indian Journal of Social Psychiatry 33:2, pages 95.
Crossref
Crossref
Johann Steiner, Paul C. Guest & Daniel Martins-de-Souza. 2017. Proteomic Methods in Neuropsychiatric Research. Proteomic Methods in Neuropsychiatric Research
3
19
.
Johann Steiner, Paul C. Guest, Hassan Rahmoune & Daniel Martins-de-Souza. 2017. Multiplex Biomarker Techniques. Multiplex Biomarker Techniques
19
35
.
Rafal A.H. Yeisen, Inge Joa, Jan Olav Johannessen & Stein Opjordsmoen. (2016) Use of medication algorithms in first episode psychosis: a naturalistic observational study. Early Intervention in Psychiatry 10:6, pages 503-510.
Crossref
Crossref
Emma E. Walter, Francesca Fernandez, Mollie Snelling & Emma Barkus. (2016) Genetic Consideration of Schizotypal Traits: A Review. Frontiers in Psychology 7.
Crossref
Crossref
Shanna Cooper, Joshua Klugman, Richard G. Heimberg, Deidre M. Anglin & Lauren M. Ellman. (2016) Attenuated positive psychotic symptoms and social anxiety: Along a psychotic continuum or different constructs?. Psychiatry Research 235, pages 139-147.
Crossref
Crossref
Valeria Del Vecchio, Mario Luciano, Gaia Sampogna, Corrado De Rosa, Domenico Giacco, Ilaria Tarricone, Francesco Catapano & Andrea Fiorillo. (2015) The role of relatives in pathways to care of patients with a first episode of psychosis. International Journal of Social Psychiatry 61:7, pages 631-637.
Crossref
Crossref
Ioannis Tsaousis, Chrysoula Zouraraki, Penny Karamaouna, Leda Karagiannopoulou & Stella G. Giakoumaki. (2015) The validity of the Schizotypal Personality Questionnaire in a Greek sample: Tests of measurement invariance and latent mean differences. Comprehensive Psychiatry 62, pages 51-62.
Crossref
Crossref
Unni Bratlien, Merete Øie, Elisabeth Haug, Paul Møller, Ole A. Andreassen, Lars Lien & Ingrid Melle. (2015) Self-reported symptoms and health service use in adolescence in persons who later develop psychotic disorders: A prospective case-control study. Early Intervention in Psychiatry 9:3, pages 221-227.
Crossref
Crossref
Barbara J Sahakian & Sharon Morein-Zamir. (2015) Pharmacological cognitive enhancement: treatment of neuropsychiatric disorders and lifestyle use by healthy people. The Lancet Psychiatry 2:4, pages 357-362.
Crossref
Crossref
Heinz Häfner. (2014) The Concept of Schizophrenia: From Unity to Diversity. Advances in Psychiatry 2014, pages 1-39.
Crossref
Crossref
Hayanna Carvalho Santos Ribeiro Silva & Ileno Izídio da Costa. (2014) Rorschach e sofrimento psíquico grave: funcionamento psíquico nas primeiras crises psicóticas. Estudos de Psicologia (Campinas) 31:3, pages 337-345.
Crossref
Crossref
Diana Wotruba, Lars Michels, Roman Buechler, Sibylle Metzler, Anastasia Theodoridou, Miriam Gerstenberg, Susanne Walitza, Spyros Kollias, Wulf Rössler & Karsten Heekeren. (2014) Aberrant Coupling Within and Across the Default Mode, Task-Positive, and Salience Network in Subjects at Risk for Psychosis. Schizophrenia Bulletin 40:5, pages 1095-1104.
Crossref
Crossref
R.K.R. Salokangas, M. Heinimaa, T. From, E. Löyttyniemi, T. Ilonen, S. Luutonen, J. Hietala, T. Svirskis, H.G. von Reventlow, G. Juckel, D. Linszen, P. Dingemans, M. Birchwood, P. Patterson, F. Schultze-Lutter, S. Ruhrmann & J. Klosterkötter. (2020) Short-term functional outcome and premorbid adjustment in clinical high-risk patients. Results of the EPOS project. European Psychiatry 29:6, pages 371-380.
Crossref
Crossref
Maude Schneider, Martial Van der Linden, Sarah Menghetti, Bronwyn Glaser, Martin Debbané & Stephan Eliez. (2014) Predominant negative symptoms in 22q11.2 deletion syndrome and their associations with cognitive functioning and functional outcome. Journal of Psychiatric Research 48:1, pages 86-93.
Crossref
Crossref
Nasrettin Sönmez, Kristin Lie Romm, Ole A Andreasssen, Ingrid Melle & Jan Ivar Røssberg. (2013) Depressive symptoms in first episode psychosis: a one-year follow-up study. BMC Psychiatry 13:1.
Crossref
Crossref
R.K.R. Salokangas, P. Dingemans, M. Heinimaa, T. Svirskis, S. Luutonen, J. Hietala, S. Ruhrmann, G. Juckel, H. Graf von Reventlow, D. Linszen, M. Birchwood, P. Patterson, F. Schultze-Lutter & J. Klosterkötter. (2020) Prediction of psychosis in clinical high-risk patients by the Schizotypal Personality Questionnaire. Results of the EPOS project. European Psychiatry 28:8, pages 469-475.
Crossref
Crossref
Raimo K. R. Salokangas, Dorien H. Nieman, Markus Heinimaa, Tanja Svirskis, Sinikka Luutonen, Tiina From, Heinrich Graf von Reventlow, Georg Juckel, Don Linszen, Peter Dingemans, Max Birchwood, Paul Patterson, Frauke Schultze-Lutter, Joachim Klosterkötter & Stephan Ruhrmann. (2012) Psychosocial outcome in patients at clinical high risk of psychosis: a prospective follow-up. Social Psychiatry and Psychiatric Epidemiology 48:2, pages 303-311.
Crossref
Crossref
Kee Jeong ParkUn Jung ChoJung Sun LeeYeon Ho JooChang Yoon Kim. (2013) The Development of Questionnaire for Relapse Assessment in Psychotic Disorder. Journal of Korean Neuropsychiatric Association 52:6, pages 417.
Crossref
Crossref
Sabine Bahn, Emanuel Schwarz, Laura W. Harris, Daniel Martins-de-Souza, Hassan Rahmoune & Paul C. Guest. (2012) Testes sanguíneos de biomarcadores para diagnóstico e tratamento de desordens mentais: foco em esquizofrenia. Archives of Clinical Psychiatry (São Paulo) 40:1, pages 02-09.
Crossref
Crossref
Masakuni Horiguchi, Kayleen E Hannaway, Adesewa E Adelekun, Karu Jayathilake & Herbert Y Meltzer. (2012) Prevention of the Phencyclidine-Induced Impairment in Novel Object Recognition in Female Rats by Co-Administration of Lurasidone or Tandospirone, a 5-HT1A Partial Agonist. Neuropsychopharmacology 37:10, pages 2175-2183.
Crossref
Crossref
Raimo K.R. Salokangas, Stephan Ruhrmann, Heinrich Graf von Reventlow, Markus Heinimaa, Tanja Svirskis, Tiina From, Sinikka Luutonen, Georg Juckel, Don Linszen, Peter Dingemans, Max Birchwood, Paul Patterson, Frauke Schultze-Lutter & Joachim Klosterkötter. (2012) Axis I diagnoses and transition to psychosis in clinical high-risk patients EPOS project: Prospective follow-up of 245 clinical high-risk outpatients in four countries. Schizophrenia Research 138:2-3, pages 192-197.
Crossref
Crossref
Smita Agarkar. (2012) A Case of Prolonged Duration of Untreated Psychosis: Barriers to Treatment and Strategies to Improve the Outcome. Clinical Schizophrenia & Related Psychoses 6:1, pages 45-48.
Crossref
Crossref
Yael Piontkewitz, Michal Arad & Ina Weiner. (2012) Tracing the development of psychosis and its prevention: What can be learned from animal models. Neuropharmacology 62:3, pages 1273-1289.
Crossref
Crossref
Linda Scoriels, Jennifer H. Barnett, Praveen K. Soma, Barbara J. Sahakian & Peter B. Jones. (2011) Effects of modafinil on cognitive functions in first episode psychosis. Psychopharmacology 220:2, pages 249-258.
Crossref
Crossref
J. Jundong, R. Kuja-Halkola, C. Hultman, N. Långström, B. M. D'Onofrio & Paul Lichtenstein. (2011) Poor school performance in offspring of patients with schizophrenia: what are the mechanisms?. Psychological Medicine 42:1, pages 111-123.
Crossref
Crossref
Y. Piontkewitz, M. Arad & I. Weiner. (2010) Risperidone Administered During Asymptomatic Period of Adolescence Prevents the Emergence of Brain Structural Pathology and Behavioral Abnormalities in an Animal Model of Schizophrenia. Schizophrenia Bulletin 37:6, pages 1257-1269.
Crossref
Crossref
Anna K. Mall, Annette Mehl, Sonja Kiko, Nikolaus Kleindienst, Hans-Joachim Salize, Christiane Hermann, Torsten Hoffmann, Martin Bohus & Regina Steil. (2011) Evaluation of a DVD-Based Self-Help Program in Highly Socially Anxious Individuals—Pilot Study. Behavior Therapy 42:3, pages 439-448.
Crossref
Crossref
Carlos Salavera, Miguel Puyuelo & Rosa Serrano. (2011) Detección temprana de la esquizofrenia en alumnos de secundaria. Boletín de AELFA 11:2, pages 61-65.
Crossref
Crossref
Diana I. Simeonova, Ashraf Attalla, Hanan Trotman, Michelle Esterberg & Elaine F. Walker. (2011) Does a parent-report measure of behavioral problems enhance prediction of conversion to psychosis in clinical high-risk adolescents?. Schizophrenia Research 130:1-3, pages 157-163.
Crossref
Crossref
Annapaola Prestia, Marina Boccardi, Samantha Galluzzi, Enrica Cavedo, Andrea Adorni, Andrea Soricelli, Matteo Bonetti, Cristina Geroldi, Panteleimon Giannakopoulos, Paul Thompson & Giovanni Frisoni. (2011) Hippocampal and amygdalar volume changes in elderly patients with Alzheimer's disease and schizophrenia. Psychiatry Research: Neuroimaging 192:2, pages 77-83.
Crossref
Crossref
Kathryn Cullen, Angela Guimaraes, Jeffrey Wozniak, Afshan Anjum, S. Schulz & Tonya White. (2011) Trajectories of Social Withdrawal and Cognitive Decline in the Schizophrenia Prodrome. Clinical Schizophrenia & Related Psychoses 4:4, pages 229-238.
Crossref
Crossref
Sabine Bahn, Richard Noll, Anthony Barnes, Emanuel Schwarz & Paul C. Guest. 2011. Biomarkers of Neurological and Psychiatric Disease. Biomarkers of Neurological and Psychiatric Disease
299
327
.
Vishal Madaan, Yael Dvir, Durga Prasad Bestha & Daniel R. Wilson. 2011. Handbook of Schizophrenia Spectrum Disorders, Volume II. Handbook of Schizophrenia Spectrum Disorders, Volume II
195
205
.
Rajiv Tandon, Henry A. Nasrallah & Matcheri S. Keshavan. (2010) Schizophrenia, “Just the Facts” 5. Treatment and prevention Past, present, and future. Schizophrenia Research 122:1-3, pages 1-23.
Crossref
Crossref
Clare M. Gibson, David L. Penn, Mitchell J. Prinstein, Diana O. Perkins & Aysenil Belger. (2010) Social skill and social cognition in adolescents at genetic risk for psychosis. Schizophrenia Research 122:1-3, pages 179-184.
Crossref
Crossref
Tejal Kaur & Kristin S. Cadenhead. 2010. Behavioral Neurobiology of Schizophrenia and Its Treatment. Behavioral Neurobiology of Schizophrenia and Its Treatment
97
121
.
Yael Piontkewitz, Yaniv Assaf & Ina Weiner. (2009) Clozapine Administration in Adolescence Prevents Postpubertal Emergence of Brain Structural Pathology in an Animal Model of Schizophrenia. Biological Psychiatry 66:11, pages 1038-1046.
Crossref
Crossref
Jair de Jesus Mari, Denise Razzouk, Rangaswamy Thara, Julian Eaton & Graham Thornicroft. (2009) Packages of Care for Schizophrenia in Low- and Middle-Income Countries. PLoS Medicine 6:10, pages e1000165.
Crossref
Crossref
Muhammad Tahir. (2009) Preventive Interventions for Schizophrenia: A Case Report. Clinical Schizophrenia & Related Psychoses 3:2, pages 117-120.
Crossref
Crossref
Rajiv Tandon, Henry A. Nasrallah & Matcheri S. Keshavan. (2009) Schizophrenia, “just the facts” 4. Clinical features and conceptualization. Schizophrenia Research 110:1-3, pages 1-23.
Crossref
Crossref